Intuitive Surgical (NASDAQ:ISRG) Trading Down 0.6% After Insider Selling

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down 0.6% on Tuesday following insider selling activity. The company traded as low as $589.00 and last traded at $592.23. 187,308 shares changed hands during trading, a decline of 90% from the average session volume of 1,792,521 shares. The stock had previously closed at $595.70.

Specifically, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 0.8 %

The firm has a market cap of $210.56 billion, a PE ratio of 92.15, a PEG ratio of 5.67 and a beta of 1.39. The business has a fifty day moving average of $555.91 and a 200-day moving average of $515.92.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter worth about $28,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. Finally, Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical in the 4th quarter worth about $31,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.